Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo.The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Employees 35,000 Market Cap 259.935B USD
Eli Lilly & Co (LLY.xnys) News Lilly's lebrikizumab demonstrated significant skin improvement and itch relief when combined with topical corticosteroids in people with atopic dermatitis in the third Phase 3 study December 21, 2021
Eli Lilly & Co (LLY)
Stay updated with Eli Lilly & Co (LLY) share price, insights, and trends. Explore trading opportunities with FP Markets Nigeria and start trading today!